BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients. A high-throughput protocol for mutation scanning of the BRCA1 and BRCA2 genes. Assessment of rare BRCA1 and BRCA2 variants of unknown significance using hierarchical modeling..